Missing Value Estimation for Compound‐Target Activity Data
暂无分享,去创建一个
Gisbert Schneider | Yusuf Tanrikulu | Rama Kondru | W Venus So | Hans-Marcus Bitter | G. Schneider | W. V. So | H. Bitter | Y. Tanrikulu | R. Kondru
[1] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[2] Hong Yan,et al. Microarray missing data imputation based on a set theoretic framework and biological knowledge , 2006, Nucleic acids research.
[3] Russ B. Altman,et al. Missing value estimation methods for DNA microarrays , 2001, Bioinform..
[4] J. Bajorath. Computational analysis of ligand relationships within target families. , 2008, Current opinion in chemical biology.
[5] Le Kang,et al. LocustDB: a relational database for the transcriptome and biology of the migratory locust (Locusta migratoria) , 2006, BMC Genomics.
[6] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[7] Iqbal Gondal,et al. Collateral missing value imputation: a new robust missing value estimation algorithm for microarray data , 2005, Bioinform..
[8] Jason H. Moore,et al. BIOINFORMATICS REVIEW , 2005 .
[9] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[10] T. H. Bø,et al. LSimpute: accurate estimation of missing values in microarray data with least squares methods. , 2004, Nucleic acids research.
[11] Ming Ouyang,et al. A meta-data based method for DNA microarray imputation , 2007, BMC Bioinformatics.
[12] J. Bajorath,et al. Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families. , 2010, Journal of medicinal chemistry.
[13] Dragos Horvath,et al. Neighborhood Behavior of in Silico Structural Spaces with Respect to in Vitro Activity Spaces-A Novel Understanding of the Molecular Similarity Principle in the Context of Multiple Receptor Binding Profiles , 2003, J. Chem. Inf. Comput. Sci..
[14] Marianne A Grant,et al. Protein structure prediction in structure-based ligand design and virtual screening. , 2009, Combinatorial chemistry & high throughput screening.
[15] J. Mestres,et al. Conciliating binding efficiency and polypharmacology. , 2009, Trends in pharmacological sciences.
[16] J. Mestres,et al. Drug‐Target Networks , 2010, Molecular informatics.
[17] R. Solé,et al. The topology of drug-target interaction networks: implicit dependence on drug properties and target families. , 2009, Molecular bioSystems.
[18] R. Solé,et al. Data completeness—the Achilles heel of drug-target networks , 2008, Nature Biotechnology.
[19] D. Botstein,et al. Singular value decomposition for genome-wide expression data processing and modeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] Wolfgang Guba,et al. From astemizole to a novel hit series of small-molecule somatostatin 5 receptor antagonists via GPCR affinity profiling. , 2007, Journal of medicinal chemistry.
[21] P. Aloy,et al. Unveiling the role of network and systems biology in drug discovery. , 2010, Trends in pharmacological sciences.
[22] G. S. Johnson,et al. An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.
[23] Shin Ishii,et al. A Bayesian missing value estimation method for gene expression profile data , 2003, Bioinform..
[24] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[25] J. Mestres,et al. In Silico Receptorome Screening of Antipsychotic Drugs , 2010, Molecular informatics.
[26] M. Milik,et al. Mapping adverse drug reactions in chemical space. , 2009, Journal of medicinal chemistry.
[27] Jin-Kao Hao,et al. Pattern Recognition in Bioinformatics , 2013, Lecture Notes in Computer Science.
[28] Marvin Johnson,et al. Concepts and applications of molecular similarity , 1990 .
[29] Kui Zhang,et al. Application of imputation methods to the analysis of rheumatoid arthritis data in genome-wide association studies , 2009, BMC proceedings.
[30] Ao Li,et al. Missing value estimation for DNA microarray gene expression data by Support Vector Regression imputation and orthogonal coding scheme , 2006, BMC Bioinformatics.
[31] Craig K. Enders,et al. An introduction to modern missing data analyses. , 2010, Journal of school psychology.
[32] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[33] Iqbal Gondal,et al. How to Improve Postgenomic Knowledge Discovery Using Imputation , 2009, EURASIP J. Bioinform. Syst. Biol..
[34] Philip E. Bourne,et al. A Multidimensional Strategy to Detect Polypharmacological Targets in the Absence of Structural and Sequence Homology , 2010, PLoS Comput. Biol..
[35] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[36] John P. Overington,et al. Role of open chemical data in aiding drug discovery and design. , 2010, Future medicinal chemistry.
[37] Guohui Lin,et al. Iterated Local Least Squares Microarray Missing Value Imputation , 2006, J. Bioinform. Comput. Biol..
[38] Tudor I. Oprea,et al. Quantifying the Relationships among Drug Classes , 2008, J. Chem. Inf. Model..
[39] A. Legedza,et al. An Overview of Practical Approaches for Handling Missing Data in Clinical Trials , 2009, Journal of biopharmaceutical statistics.
[40] Jason Weston,et al. SVM-Fold: a tool for discriminative multi-class protein fold and superfamily recognition , 2007, BMC Bioinformatics.
[41] P Schneider,et al. Self-organizing maps in drug discovery: compound library design, scaffold-hopping, repurposing. , 2009, Current medicinal chemistry.
[42] Bin Chen,et al. PubChem as a Source of Polypharmacology , 2009, J. Chem. Inf. Model..
[43] Kimito Funatsu,et al. Quantitative Prediction of Regioselectivity Toward Cytochrome P450/3A4 Using Machine Learning Approaches , 2010, Molecular informatics.
[44] Nicole A. Lazar,et al. Statistical Analysis With Missing Data , 2003, Technometrics.
[45] Gene H. Golub,et al. Missing value estimation for DNA microarray gene expression data: local least squares imputation , 2005, Bioinform..
[46] Michael T. M. Emmerich,et al. A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization , 2010, BMC Bioinformatics.
[47] Ki-Yeol Kim,et al. Reuse of imputed data in microarray analysis increases imputation efficiency , 2004, BMC Bioinformatics.
[48] Yuan Ren,et al. Classification for high-throughput data with an optimal subset of principal components , 2009, Comput. Biol. Chem..
[49] A Rogier T Donders,et al. Unpredictable bias when using the missing indicator method or complete case analysis for missing confounder values: an empirical example. , 2010, Journal of clinical epidemiology.
[50] Ming Ouyang,et al. Gaussian mixture clustering and imputation of microarray data , 2004, Bioinform..
[51] Qingxia Chen,et al. Missing covariate data in medical research: to impute is better than to ignore. , 2010, Journal of clinical epidemiology.
[52] Dragos Horvath,et al. Neighborhood Behavior of in Silico Structural Spaces with Respect to In Vitro Activity Spaces-A Benchmark for Neighborhood Behavior Assessment of Different in Silico Similarity Metrics , 2003, J. Chem. Inf. Comput. Sci..
[53] Laszlo Urban,et al. Phenotypic screening: Fishing for neuroactive compounds. , 2010, Nature chemical biology.
[54] Andrew L. Hopkins,et al. Drug discovery: Predicting promiscuity , 2009, Nature.
[55] Dieter Müller,et al. Pathway analysis tools and toxicogenomics reference databases for risk assessment. , 2008, Pharmacogenomics.
[56] Tero Aittokallio,et al. Improving missing value estimation in microarray data with gene ontology , 2006, Bioinform..